Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Oien

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Virology|January 15, 2003
Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agentsDarrell R Thomsen, Nancee L Oien, Todd A Hopkins, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|October 14, 2006
Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the damsMichael A Ellsworth, Kris K Fairbanks, Stephen Behan, et al.
Journal of the American Veterinary Medical Association|May 13, 2016
Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory diseaseSuman M Mahan, Brian Sobecki, John Johnson, et al.
Bioorganic & Medicinal Chemistry|March 25, 2000
Structure-activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitorsJ A Tucker, T L Clayton, C G Chidester, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymeraseV A Vaillancourt, M M Cudahy, S A Staley, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerasesMark E Schnute, Michele M Cudahy, Roger J Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibitionMark E Schnute, Roger J Brideau, Sarah A Collier, et al.
Antiviral Research|March 13, 2002
Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesvirusesRoger J Brideau, Mary L Knechtel, Audris Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymeraseSteven P Tanis, Joseph W Strohbach, Timothy T Parker, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2010
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubilityJames A Nieman, Sajiv K Nair, Steven E Heasley, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Virology|January 15, 2003
Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agentsDarrell R Thomsen, Nancee L Oien, Todd A Hopkins, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|October 14, 2006
Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the damsMichael A Ellsworth, Kris K Fairbanks, Stephen Behan, et al.
Journal of the American Veterinary Medical Association|May 13, 2016
Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory diseaseSuman M Mahan, Brian Sobecki, John Johnson, et al.
Bioorganic & Medicinal Chemistry|March 25, 2000
Structure-activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitorsJ A Tucker, T L Clayton, C G Chidester, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymeraseV A Vaillancourt, M M Cudahy, S A Staley, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerasesMark E Schnute, Michele M Cudahy, Roger J Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibitionMark E Schnute, Roger J Brideau, Sarah A Collier, et al.
Antiviral Research|March 13, 2002
Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesvirusesRoger J Brideau, Mary L Knechtel, Audris Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymeraseSteven P Tanis, Joseph W Strohbach, Timothy T Parker, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2010
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubilityJames A Nieman, Sajiv K Nair, Steven E Heasley, et al.
Pageof 3